Development of selective CBP/P300 benzoxazepine bromodomain inhibitors (Journal of Medicinal Chemistry, 2016)

(untitled) - Popp, T; Tallant, C; Rogers, C; Fedorov, O; Brennan, P; Müller, S; Knapp, S; Bracher, F